EOLO PHARMA

General Information

Company Name

EOLO PHARMA

Founded Year

2017

Location (Offices)

San Francisco, United States +1

Founders / Decision Makers

Number of Employees

Industries

Biopharma, Biotechnology, Health Care +1

Funding Stage

Series Unknown

Social Media

EOLO PHARMA - Company Profile

EOLO PHARMA is a biotechnology company founded in 2017. The company is focused on drug discovery, specifically on developing novel molecules for the treatment of obesity. Operating within the Biopharma, Biotechnology, Health Care, and Pharmaceutical industries, EOLO PHARMA is headquartered in the United States. The most recent milestone for EOLO PHARMA is the $1.80M Venture Round investment it secured on February 8, 2023. This financial backing will undoubtedly contribute to the company's ongoing research and development efforts, as well as its overall growth trajectory. As a biotechnology company specializing in obesity treatment, EOLO PHARMA occupies a significant position within the healthcare and biopharmaceutical sectors. This recent investment is a testament to the continued potential and promise that the industry sees in EOLO PHARMA's innovative approach to drug discovery.

Taxonomy: Drug Discovery, Obesity Treatment, Chronic Inflammation, Pharmaceuticals, Molecular Drugs, Inflammation-related Diseases, Small Molecules, Research and Development, Molecular Basis, Cellular Basis, Drug Development, Biomedical Technology, Therapeutic Molecules, Biomedical Research